Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?
心臟衰竭伴有減少射出分數的四重療法序列:這真的重要嗎?
Heart Fail Clin 2024-08-31
Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States.
美國心衰竭患者降低射血分數四重療法的成本效益。
Circ Cardiovasc Qual Outcomes 2023-06-24
Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy.
HFrEF 的指導方針醫學治療:序列策略和拯救生命藥物治療的障礙。
Heart Fail Rev 2023-11-02
Initiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger!
心力衰竭患者指南建議藥物治療的啟動和逐步增量:更好、更快、更強大!
Card Fail Rev 2024-03-28
Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium.
心臟衰竭伴隨降低射血分數的四重療法之外及目前的治療策略:具潛力成為治療武器庫一部分的藥物治療。
Int J Mol Sci 2024-03-30
Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical Therapy for Newly Diagnosed Heart Failure.
新診斷心力衰竭患者快速開始四藥聯合治療的資格和預期效益。
JACC Heart Fail 2024-04-10
Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis.
心臟衰竭患者降低射出分數的藥物治療:系統性回顧與荟萃分析。
Chin Med J (Engl) 2024-05-29
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience.
心力衰竭四柱療法早期同步引入策略:單一中心經驗的結果。
Am J Cardiovasc Drugs 2024-06-23